GlassScriptPhysician profile
Ariella Price
NPI 1982101655
$1,120.51
in general payments reported to CMS, 2019-2025
16 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $40.18 · 2023: $398 · 2024: $355 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,080.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $192.88 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $150.05 | 2023-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Pfizer INC. | $135.26 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $105.09 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $90.42 | 2023-2025 | |
| Organon LLC | $89.76 | 2023-2025 | Nexplanon |
| Millicent US INC | $62.12 | 2024-2025 | Intrarosa, Femring |
| Exeltis, USA INC. | $60.65 | 2023 | Slynd |
| Merck Sharp & Dohme LLC | $57.01 | 2023-2024 | Keytruda, Gardasil 9 |
| Abbvie INC. | $41.23 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.73 | 2025 | |
| Baxter Healthcare | $32.29 | 2024 | Tisseel |
| Biogen, INC. | $21.80 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $18.96 | 2023 | Paragard T 380a |
| Avion Pharmaceuticals | $15.24 | 2023 | Balcoltra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $9.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariella Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.